All News

Phase 2 APPLY-PNH trial shows positive results superiority vs anti-C5 treatment in adult patients with PNH with residual anemia despite prior therapy.

Strengthening partnerships with healthcare professionals and driving awareness on the clinical benefits of dermatological skincare is the key to success in the public health space.

ASCP 2022 session presenters review the evidence that tipped the scales against the use of aspirin for primary prevention in patients aged 60 years or older.

The indication is approved under accelerated approval based on response rate, and continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Research suggests that positron emission tomography scans are effective at detecting early and late Hodgkin’s lymphoma, and the results could help manage and reduce toxicity from current chemotherapies.

Understanding the novel mechanisms of multiple myeloma can help to develop better next-generation therapies that overcome drug resistance.

Study results indicate durable immune response from bivalent booster after 3 months of follow-up.

Highest prevalence is seen among adults, outpatients, and women and can cause persistent severe anosmia or hyposmia, findings indicate.

In a panel, pharmacy technicians across the world discuss what immunizations and point-of-care testing looks like in United States, Portugal, and the United Kingdom.

In this month's generic products roundup, Cipla and Lupin have expanded with new products.

In a multivariable analysis, treatment with carboplatin is favored for extensive-stage cell lung cancer, even if it is not found to increase overall survival compared to standard care.

Answering questions, monitoring, medication therapy, lifestyle modifications help prevent type 2 diabetes.

These study findings may have implications for monitoring for the development of ICANS in patients receiving CAR T-cell therapies for cancer, according to the authors.

Food insecurity has previously been linked to adverse cardiovascular outcomes, but research is limited regarding the local food environment and the association with death from heart failure.

Patient-related factors and external support are influential in vulnerable patients' medication adherence.

The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.

ASCP 2022 session presenters discuss medications that can cause QTc prolongation, with a particular emphasis on a review of the literature with regards to QTc prolongation and antipsychotics.

In patients with hypoxic-ischemic brain injury, researchers observed no significant difference between liberal and restrictive oxygenation on any-cause death.

The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.

Redesigning stores with special OTC areas for older patients can enhance communication, education.

SGLT-2 inhibitors, GLP-1 receptor agonists, and a non-steroidal mineralocorticoid receptor are all showing promise in the prevention and management of diabetic kidney disease.

People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.

News research results in Zambia also find that early intervention in the form of antiretroviral therapies and better nutrition may help close the gap.

Patients with synchronous liver metastases from colorectal cancer have been found to have worse outcomes than those with metachronous liver metastases.

Research shows that patients with a severe form of psoriasis have a higher risk of death from cardiovascular disease.

The efficacy of Shingrix was 97% in adults 50 years of age and older and 91% in adults 70 years of age and older over an extended follow-up period.

By supporting pharmacy students at Howard University, the fellowship hopes to expand the number of pharmacists of color in industry.

ASCP 2022 session presenters discuss strategies and tools that can help busy pharmacists stay up to date on current medical literature, guidelines, and media.

Expanding capacity of health care outcomes statutes aims to link specialists with general practices.